Palliative Radiofrequency Ablation Accelerates the Residual Tumor Progression Through Increasing Tumor-Infiltrating MDSCs and Reducing T-Cell-Mediated Anti-Tumor Immune Responses in Animal Model

Previous studies showed that radiofrequency ablation (RFA) has a favorable treatment efficacy for hepatocellular carcinoma (HCC) or colorectal liver metastases (CRLMs). Palliative RFA (pRFA) resulting from larger HCC or multiple CRLMs further accelerated the progression of potential residual tumor,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hao, Li, Su-shu, Zhou, Meijun, Jiang, An-Na, He, Yanni, Wang, Song, Yang, Wei, Liu, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498645/
https://www.ncbi.nlm.nih.gov/pubmed/33014771
http://dx.doi.org/10.3389/fonc.2020.01308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498645/
https://www.ncbi.nlm.nih.gov/pubmed/33014771
http://dx.doi.org/10.3389/fonc.2020.01308

Ejemplares similares